Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hagerman

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Acta Neuropathologica|June 25, 2013
Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanismsPaul Hagerman
The Lancet. Neurology|July 23, 2013
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndromeRandi Hagerman, Paul Hagerman
Current Opinion in Neurology|May 14, 2021
Fragile X-associated tremor/ataxia syndrome: pathophysiology and managementRandi Hagerman, Paul Hagerman
Nature Reviews. Neurology|June 25, 2016
Fragile X-associated tremor/ataxia syndrome - features, mechanisms and managementRandi J Hagerman, Paul Hagerman
Molecular Autism|September 23, 2010
Fragile X and autism: Intertwined at the molecular level leading to targeted treatmentsRandi Hagerman, Gry Hoem, Paul Hagerman
Journal of Neurodevelopmental Disorders|May 28, 2011
FMR1 premutation and full mutation molecular mechanisms related to autismRandi Hagerman, Jacky Au, Paul Hagerman
Cerebellum (London, England)|June 5, 2016
Cerebellar Mild Iron Accumulation in a Subset of FMR1 Premutation Carriers with FXTASHailee Rogers, Jeanelle Ariza, Angela Monterrubio, et al.
Bioinformatics (Oxford, England)|September 27, 2003
Transformation and normalization of oligonucleotide microarray dataSue C Geller, Jeff P Gregg, Paul Hagerman, et al.
RNA (New York, N.Y.)|January 8, 2003
Reduced FMR1 mRNA translation efficiency in fragile X patients with premutationsBeatrice Primerano, Flora Tassone, Randi J Hagerman, et al.
Clinical Case Reports|May 5, 2017
<i>FMR1</i> premutation with Prader-Willi phenotype and fragile X-associated tremor/ataxia syndromeVerónica Martínez-Cerdeño, Mirna Lechpammer, Stephen Noctor, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Acta Neuropathologica|June 25, 2013
Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanismsPaul Hagerman
The Lancet. Neurology|July 23, 2013
Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndromeRandi Hagerman, Paul Hagerman
Current Opinion in Neurology|May 14, 2021
Fragile X-associated tremor/ataxia syndrome: pathophysiology and managementRandi Hagerman, Paul Hagerman
Nature Reviews. Neurology|June 25, 2016
Fragile X-associated tremor/ataxia syndrome - features, mechanisms and managementRandi J Hagerman, Paul Hagerman
Molecular Autism|September 23, 2010
Fragile X and autism: Intertwined at the molecular level leading to targeted treatmentsRandi Hagerman, Gry Hoem, Paul Hagerman
Journal of Neurodevelopmental Disorders|May 28, 2011
FMR1 premutation and full mutation molecular mechanisms related to autismRandi Hagerman, Jacky Au, Paul Hagerman
Cerebellum (London, England)|June 5, 2016
Cerebellar Mild Iron Accumulation in a Subset of FMR1 Premutation Carriers with FXTASHailee Rogers, Jeanelle Ariza, Angela Monterrubio, et al.
Bioinformatics (Oxford, England)|September 27, 2003
Transformation and normalization of oligonucleotide microarray dataSue C Geller, Jeff P Gregg, Paul Hagerman, et al.
RNA (New York, N.Y.)|January 8, 2003
Reduced FMR1 mRNA translation efficiency in fragile X patients with premutationsBeatrice Primerano, Flora Tassone, Randi J Hagerman, et al.
Clinical Case Reports|May 5, 2017
<i>FMR1</i> premutation with Prader-Willi phenotype and fragile X-associated tremor/ataxia syndromeVerónica Martínez-Cerdeño, Mirna Lechpammer, Stephen Noctor, et al.
Pageof 4